The fear of beta-blocker therapy in heart failure: time to forget.
Chatterjee
Kanu
K
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced / Q000453:epidemiology; D004244:Dizziness / Q000139:chemically induced / Q000453:epidemiology; D005221:Fatigue / Q000139:chemically induced / Q000453:epidemiology; D006329:Heart Conduction System / Q000187:drug effects / Q000473:pathology; D006333:Heart Failure / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000453:epidemiology; D040242:Risk Reduction Behavior; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000453:epidemiology; D028761:Withholding Treatment
D000319:Adrenergic beta-Antagonists